Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Patrick Smith Insider Profile
11 Followers
Patrick Smith, CEO, Director at Axon Enterprise, holds 1.79M shares in OncoCyte (Ticker: OCX), holds 2.88M shares in Axon Enterprise (Ticker: AXON). Most recently, Patrick Smith Bought ― shares of OncoCyte on Jan 15, 2025 for an estimated value of 34.11K.
Profitable Transactions
3 out of 10 Profitable Transactions
Average Return
-10.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Patrick Smith holds in companies
Most Profitable Insider Trade
The most profitable trade made by Patrick Smith
Patrick Smith's Trading History
Axon Enterprise
Dec 17, 2024
CEO, Director
Uninformative Sell
―
$1.71B
OncoCyte
Jan 15, 2025
Ten Percent Owner
Informative Buy
34.11K
$3.72M
List of latest transactions for each holding click on a transaction to see Patrick Smith's performance on stock
You May Also Like
Patrick Smith insider profile FAQ
What is the percentage of profitable transactions made by Patrick Smith?
The percentage of profitable transactions made by Patrick Smith is 30%.
What is the average return per transaction made by Patrick Smith?
The average return per transaction made by Patrick Smith is -10.30%.
What stocks does Patrick Smith hold?
Patrick Smith holds: AXON, OCX stocks.
What was Patrick Smith’s latest transaction?
Patrick Smith latest transaction was an Informative Buy of $34.11K.
What was Patrick Smith's most profitable transaction?
Patrick Smith’s most profitable transaction was an Informative Sell of AXON stock on May 11, 2015. The return on the trade was 40.30%.
What is Patrick Smith's role in Axon Enterprise?
Patrick Smith's role in Axon Enterprise is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.